Target intelligence / Profile preview

Nucleic acids (DNA and RNA) (DNA/RNA)

Target
DNA/RNA
Molecular classification
Nucleic acid, Other
01

Overview

Nucleic acids, comprising deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), are the fundamental molecules responsible for the storage, transmission, and expression of genetic information in all living organisms (National Human Genome Research Institute, 2023). DNA serves as the long-term repository of the genome, while various RNA species, including mRNA, tRNA, and rRNA, facilitate the translation of genetic code into functional proteins and provide regulatory control over cellular processes (Nature Education, 2014). In clinical practice, DNA has historically been a primary target for cytotoxic chemotherapies, such as alkylating agents and platinum-based drugs, which induce structural damage to halt the proliferation of malignant cells (PubMed, PMID: 28331195). More recently, RNA has emerged as a versatile therapeutic target through the development of antisense oligonucleotides and RNA interference (RNAi) technologies, which allow for the highly specific silencing of disease-associated genes or the correction of aberrant splicing (Nature Reviews Drug Discovery, 2020). Targeting nucleic acids is a cornerstone of treatment for oncology, viral infections, and rare genetic disorders, though it necessitates careful management of risks such as genotoxicity and off-target immune stimulation (PubMed, PMID: 31558516).

Other names
Deoxyribonucleic acidRibonucleic acidPolynucleotidesGenetic materialGenome
02

Mechanism of action

Therapeutic strategies targeting nucleic acids include DNA alkylation and covalent cross-linking to induce apoptosis (StatPearls, 2023), intercalation to inhibit replication and transcription, and the use of sequence-specific antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs) to degrade target mRNA or modulate splicing patterns (Nature Reviews Drug Discovery, 2020).

03

Biological functions

Genetic information storageGene expression regulationProtein synthesisCatalytic activitySignal transduction
04

Disease associations

CancerInfectionGenetic disorderAutoimmune diseaseNeurodegenerative disease
05

Safety considerations

GenotoxicityMutagenicitySecondary malignanciesMyelosuppressionOff-target hybridization effectsInnate immune activation (cytokine release)
06

Interacting drugs

Cisplatin

9 more in the full profile.

07

Biomarkers

gamma-H2AX (DNA damage marker)Circulating tumor DNA (ctDNA)RNA expression levelsMicrosatellite instability (MSI)Tumor mutational burden (TMB)

Beyond the preview

Go deeper on Nucleic acids (DNA and RNA) (DNA/RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleic acids (DNA and RNA) (DNA/RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call